Counterfeit Pharma & the Serialisation Challenge
Counterfeit pharma figures continue to grow due to increasingly complex supply chains, the increased sophistication of counterfeiters, a lack of enforcement capacity, and the expansion of e-commerce, writes Essentra's Rupert Taylor
ALREADY REGISTERED USER? SIGN IN now
Subscribe (for free) to read this article
Become a subscriber to read this story, as well as other exclusive articles and interviews. The process is entirely free and takes no time at all.